Show simple item record

dc.contributor.authorMiranda Cadena, Katherine
dc.contributor.authorMarcos Arias, Cristina
dc.contributor.authorMateo Alesanco, Estibaliz ORCID
dc.contributor.authorAguirre Urizar, José Manuel ORCID
dc.contributor.authorQuindós Andrés, Guillermo
dc.contributor.authorEraso Barrio, María Elena ORCID
dc.date.accessioned2021-11-29T08:45:36Z
dc.date.available2021-11-29T08:45:36Z
dc.date.issued2021-11
dc.identifier.citationBiomedicine & Pharmacotherapy 143 : (2021) / Article ID 112218es_ES
dc.identifier.issn0753-3322
dc.identifier.issn1950-6007
dc.identifier.urihttp://hdl.handle.net/10810/54157
dc.description.abstract[EN]Oral candidiasis is frequently associated with Candida biofilms. Biofilms are microbial communities related to persistent, recalcitrant and difficult to-treat infections. Conventional treatments are not sufficient to overcome biofilm-associated candidiasis; thus, the search of new antifungal compounds is necessary. In the current study, we have evaluated the effect of three phytocompounds, carvacrol, cinnamaldehyde and thymol, against Candida planktonic and sessile cells. Reduction in biofilm biomass and metabolic activity was assessed during adhesion and mature biofilm phases. Candida albicans was the most biofilm-producing Candida species. All phytocompounds tested were fungicidal against Candida planktonic cells. Cinnamaldehyde was the most active in inhibiting biofilm adhesion, but carvacrol and thymol significantly reduced both mature biofilm biomass and metabolic activity. These results highlight the role of cinnamaldehyde, carvacrol and thymol as promising alternatives for the treatment of candidiasis due to their antibiofilm capacities, and stress the necessity to continue studies on their safety, toxicity and pharmacodynamics and pharmacokinetics.es_ES
dc.description.sponsorshipThis work was supported by Gobierno Vasco-Eusko Jaurlaritza, Spain [grant number GIC15/78 IT-990-16, 2016] and Fundacion ONCE "Oportunidad al Talento", Spain and Fondo Social Europeo, Spain [CMA, 2018].es_ES
dc.language.isoenges_ES
dc.publisherElsevieres_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es/*
dc.subjectcandida biofilmses_ES
dc.subjectcarvacroles_ES
dc.subjectcinnamaldehydees_ES
dc.subjectthymoles_ES
dc.subjectantifungal susceptibilityes_ES
dc.titleIn vitro activities of carvacrol, cinnamaldehyde and thymol against Candida biofilmses_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.rights.holder© 2021 The Authors. This is an open access article under the CC BY-NC-ND licensees_ES
dc.rights.holderAtribución-NoComercial-SinDerivadas 3.0 España*
dc.relation.publisherversionhttps://www.sciencedirect.com/science/article/pii/S0753332221010027?via%3Dihubes_ES
dc.identifier.doi10.1016/j.biopha.2021.112218
dc.departamentoesInmunología, microbiología y parasitologíaes_ES
dc.departamentoeuImmunologia, mikrobiologia eta parasitologiaes_ES


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

© 2021 The Authors.   This is an open access article under the CC BY-NC-ND license
Except where otherwise noted, this item's license is described as © 2021 The Authors. This is an open access article under the CC BY-NC-ND license